This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Aehr Test Systems (AEHR) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Aehr Test Systems (AEHR) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Surging Earnings Estimates Signal Upside for Aehr Test Systems (AEHR) Stock
by Zacks Equity Research
Aehr Test Systems (AEHR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Best Momentum Stock to Buy for February 3rd
by Zacks Equity Research
AEHR, ALGM and ARLP made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 3, 2023.
Is Cognyte Software (CGNT) Outperforming Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Here is how Cognyte Software Ltd. (CGNT) and Aehr Test Systems (AEHR) have performed compared to their sector so far this year.
Recent Price Trend in Aehr Test Systems (AEHR) is Your Friend, Here's Why
by Zacks Equity Research
Aehr Test Systems (AEHR) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Fujifilm Downgraded on Oceania Market Distress & Macro Risks
by Zacks Equity Research
FUJIFILM Holdings Corporation's (FUJIY) near-term results might weaken due to persistent headwinds within the industry like lower Oceania market sales and stiff industry rivalry.
Philips Inks Telehealth Partnership Deal With American Well
by Zacks Equity Research
Koninklijke Philips N.V.'s (PHG) professional and consumer digital health solutions to be combined with American Well's premium virtual care capabilities for upgrading the former's Avent uGrow application.
Fitbit (FIT) Aids Keller Williams to Expand Wellness Program
by Zacks Equity Research
Fitbit's (FIT) devices are integrated with Keller Williams's wellness program.
Fitbit (FIT) Stock Gains on Settlement of Jawbone Lawsuit
by Zacks Equity Research
Fitbit's (FIT) share price jumps on a litigation settlement with Jawbone.
Aehr Test (AEHR) In Focus: Stock Adds 16.5% in Session
by Zacks Equity Research
Aehr Test Systems (AEHR) moved big last session, as its shares jumped over 16% on the day.